Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense
QFR105385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
8,095.00
Year-over-Year Change
53.02%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the interest expenses of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insight into the financial health and borrowing costs of a key sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The interest expense metric reflects the cost of debt financing for pharmaceutical companies, indicating their capital structure and financial strategy. Economists analyze this trend to understand industry investment patterns, credit conditions, and potential impacts on research and development spending.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations and compiled by the U.S. Federal Reserve.
Historical Context
This metric is used by financial analysts, investors, and policymakers to assess the economic performance and credit dynamics of the pharmaceutical sector.
Key Facts
- Represents quarterly interest expenses for U.S. pharmaceutical corporations
- Indicates borrowing costs and financial strategy in the healthcare sector
- Part of broader Federal Reserve economic tracking mechanisms
FAQs
Q: What does this trend measure?
A: It measures the total interest expenses paid by U.S. pharmaceutical and medicine corporations on their debt obligations each quarter.
Q: Why are interest expenses important for pharmaceutical companies?
A: Interest expenses reflect borrowing costs that impact research investment, drug development, and overall financial strategy in the healthcare sector.
Q: How is this data collected?
A: The data is compiled from quarterly financial reports submitted by pharmaceutical corporations to regulatory authorities.
Q: How do investors use this trend?
A: Investors analyze this trend to assess the financial health, borrowing capacity, and potential investment risks in the pharmaceutical industry.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of the sector's financial conditions.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Beverage and Tobacco Products: Total Assets
QFR223312USNO
Quarterly Financial Report: U.S. Corporations: Printing and Related Support Activities: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319323USNO
Contributions to the Chicago Fed Midwest Economy Index: Iowa Contribution: Consumer Spending Sector
CONSUIAM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Machinery: Net Working Capital
QFRNWC333USNO
Quarterly Financial Report: U.S. Corporations: Nonferrous Metals: All Other Operating Costs and Expenses
QFR103381USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Total Current Assets
QFRTCAOTRUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense [QFR105385USNO], retrieved from FRED.
Last Checked: 8/1/2025